Eli Lilly officials say the cuts come as it loses Cymbalta and Evista brands, which made up about 20 percent of Lilly‘s global corporate revenue in 2012.
IU President Michael McRobbie worries federal budget cuts could put a strain on universities relying on research funding.
The Indianapolis-based drug manufacturer plans to expand its insulin manufacturing facility.
Experimental drug shows a 34 percent reduction in memory loss for Alzheimer's patients.
Wellpoint and Eli Lilly rank among the top 100 companies.
Eli Lilly manufactures the new Alzheimer's drug.
Daniel Hasler, who has been working with the Indiana Economic Development Corporation since February, will be the new Secretary of Commerce
A breast cancer advocacy group is targeting Indiana’s largest pharmaceutical company.
A $150-million mixed use development project is being planned for downtown Indianapolis.
Derica Rice says he has no specific priorities as a trustee but has particular interest in IU's life sciences initiative.